NUTEX HEALTH INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
NUTEX HEALTH INC. (NUTX) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $21.24 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-06
- NUTEX HEALTH INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was $24.77M, a 43.82% decline year-over-year.
- NUTEX HEALTH INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $44.09M, a 450.84% increase year-over-year.
- NUTEX HEALTH INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was $8.00M.
- NUTEX HEALTH INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$1.42M.
- NUTEX HEALTH INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was $144.93M, a 677.63% increase from fiscal 2024.
- NUTEX HEALTH INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $18.64M.
- NUTEX HEALTH INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$12.25M.
- NUTEX HEALTH INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$1.86M, a 117.57% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $21.24M 10-Q · filed 2026-08-06 | |||||||
| 2026-03-31 | $24.77M 10-Q · filed 2026-04-30 | |||||||
| 2025-12-31 | $144.93M 10-K · filed 2026-03-05 | |||||||
| 2025-09-30 | $125.41M 10-Q · filed 2025-11-19 | |||||||
| 2025-06-30 | $56.09M 10-Q · filed 2026-08-06 | |||||||
| 2025-03-31 | $44.09M 10-Q · filed 2026-04-30 | |||||||
| 2024-12-31 | $18.64M 10-K · filed 2026-03-05 | $21.58M 10-K · filed 2025-03-31 | ||||||
| 2024-09-30 | $24.91M 10-Q · filed 2025-11-19 | $24.91M 10-Q · filed 2024-11-07 | ||||||
| 2024-06-30 | $18.81M 10-Q · filed 2025-11-18 | $18.81M 10-Q · filed 2024-08-08 | ||||||
| 2024-03-31 | $8.00M 10-Q/A · filed 2025-11-18 | $8.00M 10-Q · filed 2024-05-09 | ||||||
| 2023-12-31 | -$12.25M 10-K · filed 2026-03-05 | -$12.25M 10-K · filed 2024-03-29 | ||||||
| 2023-09-30 | -$7.43M 10-Q · filed 2024-11-07 | |||||||
| 2023-06-30 | -$1.50M 10-Q · filed 2024-08-08 | |||||||
| 2023-03-31 | -$1.42M 10-Q · filed 2024-05-09 | |||||||
| 2022-12-31 | -$1.86M 10-K/A · filed 2025-11-18 | |||||||
| 2022-09-30 | $502.51K 10-Q · filed 2023-11-09 | |||||||
| 2022-06-30 | $11.48M 10-Q · filed 2023-08-09 | |||||||
| 2022-03-31 | -$559.79K 10-Q · filed 2023-05-15 | -$2.60M 10-Q · filed 2022-05-13 | ||||||
| 2021-12-31 | $10.60M 10-K · filed 2024-03-29 | $15.29M 10-K · filed 2022-03-31 | ||||||
| 2021-09-30 | $8.72M 10-Q · filed 2022-11-21 | $5.98M 10-Q · filed 2021-11-15 | ||||||
| 2021-06-30 | $12.52M 10-Q · filed 2022-08-22 | $4.77M 10-Q · filed 2021-08-16 | ||||||
| 2021-03-31 | $3.71M 10-Q · filed 2022-05-13 | |||||||
| 2020-12-31 | $17.51M 10-K · filed 2023-03-03 | -$1.04M 10-K · filed 2022-03-31 | ||||||
| 2020-09-30 | -$1.04M 10-Q · filed 2021-11-15 | |||||||
| 2020-06-30 | -$1.00M 10-Q · filed 2021-08-16 | |||||||
| 2020-03-31 | -$897.70K 10-Q · filed 2021-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIQUIDITY SERVICES INC (LQDT) | United States | $1.359B | 44.69 |
| ACV Auctions Inc. (ACVA) | United States | $1.775B | -19.26 |
| Concentrix Corp (CNXC) | United States | $1.792B | -1.31 |
| Western Union CO (WU) | United States | $1.878B | 6.06 |
| TIC Solutions, Inc. (TIC) | United States | $1.936B | -15.28 |
| QUINSTREET, INC (QNST) | United States | $0.822B | 10.19 |
| Paysign, Inc. (PAYS) | United States | $0.732B | 29.27 |
| CASS INFORMATION SYSTEMS INC (CASS) | United States | $0.696B | 17.90 |
| Priority Technology Holdings, Inc. (PRTH) | United States | $0.643B | 9.77 |
| Phreesia, Inc. (PHR) | United States | $0.621B | 63.46 |